The CHRNA5-A3-B4 Gene Cluster and Smoking: From Discovery to Therapeutics

被引:56
作者
Lassi, Glenda [1 ,2 ]
Taylor, Amy E. [1 ,3 ]
Timpson, Nicholas J. [3 ]
Kenny, Paul J. [4 ,5 ]
Mather, Robert J. [6 ]
Eisen, Tim [2 ,7 ]
Munafo, Marcus R. [1 ,3 ]
机构
[1] Univ Bristol, Sch Expt Psychol, UK Ctr Tobacco & Alcohol Studies, Bristol, Avon, England
[2] AstraZeneca, Early Clin Dev, Oncol Translat Med Unit, Cambridge, England
[3] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England
[4] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA
[5] Icahn Sch Med Mt Sinai, Expt Therapeut Inst, New York, NY 10029 USA
[6] AstraZeneca, Neurosci IMED, Cambridge, MA USA
[7] Univ Cambridge, Dept Oncol, Cambridge, England
基金
英国经济与社会研究理事会; 英国医学研究理事会;
关键词
NICOTINIC ACETYLCHOLINE-RECEPTORS; HIGH TOBACCO CONSUMPTION; MENDELIAN RANDOMIZATION; LUNG-CANCER; RISK-FACTOR; DEPENDENCE; SCHIZOPHRENIA; ASSOCIATION; SUBUNIT; 15Q25;
D O I
10.1016/j.tins.2016.10.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Genome-wide association studies (GWASs) have identified associations between the CHRNA5-CHRNA3-CHRNB4 gene cluster and smoking heaviness and nicotine dependence. Studies in rodents have described the anatomical localisation and function of the nicotinic acetylcholine receptors (nAChRs) formed by the subunits encoded by this gene cluster. Further investigations that complemented these studies highlighted the variability of individuals' smoking behaviours and their ability to adjust nicotine intake. GWASs of smoking-related health outcomes have also identified this signal in the CHRNA5-CHRNA3-CHRNB4 gene cluster. This insight underpins approaches to strengthen causal inference in observational data. Combining genetic and mechanistic studies of nicotine dependence and smoking heaviness may reveal novel targets for medication development. Validated targets can inform genetic therapeutic interventions for smoking cessation and tobacco-related diseases.
引用
收藏
页码:851 / 861
页数:11
相关论文
共 56 条
[1]   Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio [J].
Allenby, Cheyenne E. ;
Boylan, Kelly A. ;
Lerman, Caryn ;
Falcone, Mary .
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2016, 11 (03) :471-483
[2]  
[Anonymous], 2015, BMJ OPEN
[3]   Causal associations of tobacco smoking with cardiovascular risk factors: a Mendelian randomization analysis of the HUNT Study in Norway [J].
Asvold, Bjorn O. ;
Bjorngaard, Johan H. ;
Carslake, David ;
Gabrielsen, Maiken E. ;
Skorpen, Frank ;
Smith, George Davey ;
Romundstad, Pal R. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2014, 43 (05) :1458-1470
[4]   α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking [J].
Berrettine, W. ;
Yuan, X. ;
Tozzi, F. ;
Song, K. ;
Francks, C. ;
Chilcoat, H. ;
Waterworth, D. ;
Muglia, P. ;
Mooser, V. .
MOLECULAR PSYCHIATRY, 2008, 13 (04) :368-373
[5]   The CHRNA5-A3-B4 gene cluster in nicotine addiction [J].
Berrettini, W. H. ;
Doyle, G. A. .
MOLECULAR PSYCHIATRY, 2012, 17 (09) :856-866
[6]   Variants in nicotinic receptors and risk for nicotine dependence [J].
Bierut, Laura Jean ;
Stitzel, Jerry A. ;
Wang, Jen C. ;
Hinrichs, Anthony L. ;
Grucza, Richard A. ;
Xuei, Xiaoling ;
Saccone, Nancy L. ;
Saccone, Scott F. ;
Bertelsen, Sarah ;
Fox, Louis ;
Horton, William J. ;
Breslau, Naomi ;
Budde, John ;
Cloninger, C. Robert ;
Dick, Danielle M. ;
Foroud, Tatiana ;
Hatsukami, Dorothy ;
Hesselbrock, Victor ;
Johnson, Eric O. ;
Kramer, John ;
Kuperman, Samuel ;
Madden, Pamela A. F. ;
Mayo, Kevin ;
Nurnberger, John, Jr. ;
Pomerleau, Ovide ;
Porjesz, Bernice ;
Reyes, Oliver ;
Schuckit, Marc ;
Swan, Gary ;
Tischfield, Jay A. ;
Edenberg, Howard J. ;
Rice, John P. ;
Goate, Alison M. .
AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (09) :1163-1171
[7]   Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression [J].
Bowden, Jack ;
Smith, George Davey ;
Burgess, Stephen .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (02) :512-525
[8]   Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation [J].
Chen, Li-Shiun ;
Baker, Timothy B. ;
Jorenby, Douglas ;
Piper, Megan ;
Saccone, Nancy ;
Johnson, Eric ;
Breslau, Naomi ;
Hatsukami, Dorothy ;
Carney, Robert M. ;
Bierut, Laura J. .
DRUG AND ALCOHOL DEPENDENCE, 2015, 154 :278-282
[9]  
Cheng JZ, 2016, SCI REP-UK, V6, DOI [10.1038/srep24454, 10.1038/srep25671]
[10]   BMI as a Modifiable Risk Factor for Type 2 Diabetes: Refining and Understanding Causal Estimates Using Mendelian Randomization [J].
Corbin, Laura J. ;
Richmond, Rebecca C. ;
Wade, Kaitlin H. ;
Burgess, Stephen ;
Bowden, Jack ;
Smith, George Davey ;
Timpson, Nicholas J. .
DIABETES, 2016, 65 (10) :3002-3007